PFIZER
Pfizer Limited (PFIZER) Stock Analysis
Pfizer Limited markets vaccines, pharmaceuticals, and consumer health products in India, backed by global Pfizer research. It focuses on innovative therapies, hospital products, and primary care medicines. The company serves doctors, hospitals, and retail pharmacies nationwide. It is listed on Indian stock exchanges as the Indian arm of Pfizer.
Healthcare › Drug Manufacturers - General
₹3,814.00
+0.15% 1W | -28.40% 52W
Market Cap
17.4k CR
P/E Ratio
23.7
52W High
₹5446
52W Low
₹3731
Div. Yield
1.97%
Beta
0.1
50 DMA
₹4335.6
200 DMA
₹4629.3
Profit Margin
28.6%
Inst. Own.
15.5%
🚀 BREAKOUT
🚀 BREAKOUT
Fundamentals
Profit & Loss
No profit & loss data available.
| Metric | Nov 2006 | Nov 2007 | Nov 2008 |
|---|---|---|---|
| Sales | 664 | 676 | 678 |
| Expenses | 537 | 815 | 760 |
| Operating Profit | 127 | -139 | -82 |
| OPM % | 19% | -21% | -12% |
| Other Income | 48 | 600 | 512 |
| Interest | 0 | 0 | 0 |
| Depreciation | 13 | 10 | 11 |
| Profit before tax | 163 | 451 | 419 |
| Tax % | 35% | 25% | 29% |
| Net Profit | 106 | 340 | 300 |
| EPS in Rs | 35.64 | 113.94 | 100.39 |
| Dividend Payout % | 63% | 24% | 12% |
Shareholding Pattern
Promoters63.92%
FIIs2.60%
DIIs17.11%
Public16.37%
Promoters63.92%
FIIs2.71%
DIIs17.05%
Public16.32%
Promoters63.92%
FIIs2.81%
DIIs16.89%
Public16.36%
Promoters63.92%
FIIs1.65%
DIIs17.80%
Public16.62%
Promoters63.92%
FIIs1.63%
DIIs17.52%
Public16.93%
Promoters63.92%
FIIs2.80%
DIIs14.89%
Public18.38%
Promoters63.92%
FIIs3.32%
DIIs15.32%
Public17.42%
Promoters63.92%
FIIs2.18%
DIIs17.10%
Public16.79%
Promoters63.92%
FIIs2.81%
DIIs16.89%
Public16.36%
Promoters63.92%
FIIs1.63%
DIIs17.52%
Public16.93%
PFIZER
Holdings Analysis
Key strengths & risk signals
51
Overall
58
Fundamental
45
Technical
Risks (4)
OVERVALUED! PEG of 4.74 means expensive relative to growth rate.
POOR YEAR! Stock declined 28.4% in the last year.
BEARISH SENTIMENT! In last 30 days: 10 up days, 20 down days. Avg volume on up days: 24,162 vs down days: 69,141. Ratio: 0.35x
WEAK POSITION! Current price (3814.0) is below both moving averages.
Strengths (4)
EXCELLENT EFFICIENCY! 28.6% profit margin - company keeps strong profits.
BREAKOUT! Stock has broken above resistance levels with momentum.
LOW VOLATILITY! Beta of 0.10 - stable stock, less market risk.
APPROACHING OVERSOLD! RSI at 36.2 - watch for reversal.
Fundamental & Technical Analysis
51Overall
58Fundamental
45Technical
Fundamental Breakdown
Growth Quality
10/30
Revenue CAGR: 1.3% (SLOW, 5/15). Profit CAGR: 5.0% (SLOW, 5/15).
Profit Margin
9/10
EXCELLENT EFFICIENCY! 28.6% profit margin - company keeps strong profits.
PEG Valuation
0/10
OVERVALUED! PEG of 4.74 means expensive relative to growth rate.
Dividend Yield
5/10
LOW DIVIDEND! 1.97% yield - minimal income contribution.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
16/20
LESS PUBLIC HOLDING! 18.37% public ownership - good institutional/promoter control.
Stability Index
8/10
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
Technical Breakdown
Moving Averages
5/10
BEARISH TREND! 50-day average (4335.6) is below 200-day average (4629.3) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (3814.0) is below both moving averages.
Trend Pattern
20/20
BREAKOUT! Stock has broken above resistance levels with momentum.
52W Performance
1/10
POOR YEAR! Stock declined 28.4% in the last year.
Volume Sentiment
5/30
BEARISH SENTIMENT! In last 30 days: 10 up days, 20 down days. Avg volume on up days: 24,162 vs down days: 69,141. Ratio: 0.35x
RSI
4/5
APPROACHING OVERSOLD! RSI at 36.2 - watch for reversal.
52W Range
1/5
WEAK! Trading at 4.8% of 52W range - near yearly lows.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - 0.1% (1 week), -5.0% (1 month), -16.5% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.10 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - General · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PFIZER | ₹3,814.00 | 23.7 | 28.6% | 1.3% | 5.0% | -28.4% | 51 | BREAKOUT | +6.6% | +2.4% | +8.3% | +3.8% |
| MARKSANS | ₹311.00 | 27.3 | 16.3% | 16.7% | 16.2% | +73.9% | 70 | BREAKDOWN | +169.6% | +6.1% | +35.6% | -1.8% |
| SANOFICONR | ₹3,548.70 | 30.7 | 28.0% | 27.0% | 20.7% | -22.8% | 69 | BREAKDOWN | +13.3% | +1.5% | +6.7% | +2.8% |
| SANOFI | ₹2,942.10 | 20.9 | 17.9% | -12.6% | -19.3% | -36.8% | 57 | APPROACHING SUPPORT | +20.1% | -18.6% | +7.7% | -7.3% |
| SENORES | ₹1,318.40 | 46.4 | 18.7% | 159.1% | 139.2% | +79.3% | 77 | APPROACHING RESISTANCE | +55.8% | -2.8% | +35.9% | +2.9% |
| RUBICON | ₹1,508.60 | 86.9 | 14.9% | 36.6% | – | +138.7% | 68 | BREAKDOWN | – | +10.4% | +51.6% | +4.0% |
| SMSPHARMA | ₹450.50 | 40.1 | 11.4% | 19.3% | – | +44.6% | 74 | BREAKDOWN | +2.0% | -36.1% | +5.6% | -13.0% |
| SAIPARENT | ₹487.30 | 168 | 3.9% | 126.1% | 111.8% | +19.3% | 67 | APPROACHING RESISTANCE | +464.3% | -1,416.7% | +435.0% | -33.6% |
Data from TradeAlone · Updated daily
No news tagged for PFIZER yet.
